Target intelligence / Profile preview

Phagocyte NADPH oxidase complex (NOX2)

Target
NOX2
Molecular classification
Enzyme, Oxidoreductase, Multimeric protein complex
01

Overview

The phagocyte NADPH oxidase (NOX2) complex is the primary enzymatic machinery responsible for the respiratory burst in neutrophils, a process essential for innate immunity (Bedard & Krause, 2007). This multicomponent system consists of the membrane-bound cytochrome b558 (composed of gp91phox and p22phox) and several cytosolic subunits (p47phox, p67phox, p40phox, and the small GTPase Rac) that assemble at the phagosomal or plasma membrane upon activation (Panday et al., 2015). Its main function is to catalyze the transfer of electrons from NADPH to molecular oxygen, generating superoxide anions, which serve as precursors for other microbicidal reactive oxygen species (ROS) like hydrogen peroxide and hypochlorous acid (Lambeth, 2004). While crucial for pathogen killing, excessive or chronic activation of this machinery contributes to tissue injury in inflammatory, cardiovascular, and neurodegenerative diseases (Roos et al., 2003). Conversely, genetic deficiencies in any of the NOX2 subunits lead to Chronic Granulomatous Disease (CGD), a primary immunodeficiency characterized by life-threatening infections and granuloma formation (StatPearls, 2023). Therapeutic strategies targeting this machinery focus on small-molecule inhibitors to dampen oxidative stress in chronic inflammation, though maintaining a balance to avoid immunosuppression remains a significant challenge.

Other names
Neutrophil oxidant release machineryRespiratory burst oxidasePhoxgp91phox complexNADPH oxidase 2Cytochrome b558
02

Mechanism of action

Inhibition of the enzymatic conversion of molecular oxygen to superoxide anions by blocking electron transfer within the NOX2 complex or preventing the assembly of its cytosolic and membrane-bound subunits.

03

Biological functions

Immune responseReactive oxygen species productionPathogen killingSignal transductionPhagocytosis
04

Disease associations

InflammationChronic Granulomatous DiseaseAutoimmune diseaseCardiovascular diseaseNeurodegenerative diseaseInfection
05

Safety considerations

Increased susceptibility to bacterial and fungal infections (e.g., Staphylococcus aureus, Aspergillus)Impaired phagocytic killingPotential for inducing a phenotype similar to Chronic Granulomatous Disease (CGD)Impaired wound healing
06

Interacting drugs

GSK2795039

4 more in the full profile.

07

Biomarkers

Dihydrorhodamine 123 (DHR) flow cytometryNitroblue tetrazolium (NBT) reduction testChemiluminescence (Luminol/Lucigenin) assaySuperoxide dismutase-inhibitable ferricytochrome c reduction

Beyond the preview

Go deeper on Phagocyte NADPH oxidase complex (NOX2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phagocyte NADPH oxidase complex (NOX2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call